Cart
0
Product
Products
(empty)
No products
To be determined
Shipping
$0.00
Total
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart.
There is 1 item in your cart.
Total products
Total shipping
To be determined
Total
Sale!
View larger
View larger
DIN 58989:2018-10
New product
DIN 58989:2018-10
Haemostaseology - HPLC-MS methods for the quantification of direct oral anticoagulants (DOAC) - Rivaroxaban; Text in German and EnglishMore info
Rivaroxaban [rINN] is an oral, highly selective direct Factor Xa (FXa) Inhibitor and has an anti-coagulatory effect. This standard describes methods for measuring concentrations of the direct oral anticoagulant (DOAC) rivaroxaban in human plasma samples. This document is applicable to developers and manufacturers of rivaroxaban assays, medical laboratories, as well as institutions and commercial organizations performing biomedical research.
| Author | DIN |
|---|---|
| Editor | DIN |
| Document type | Standard |
| Format | File |
| ICS | 11.100.30 : Analysis of blood and urine
|
| Number of pages | 24 |
| Replace | DIN 58989 (2017-11) |
| Year | 2018 |
| Document history | DIN 58989 (2018-10) |
| Country | Germany |
| Keyword | 58989 |